Cite
Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network.
MLA
Guirguis-Blake, Janelle, et al. “Prescription of High-Risk Medications among Patients with Chronic Kidney Disease: A Cross-Sectional Study from the Washington, Wyoming, Alaska, Montana and Idaho Region Practice and Research Network.” Family Practice, vol. 35, no. 5, Oct. 2018, pp. 589–94. EBSCOhost, https://doi.org/10.1093/fampra/cmy001.
APA
Guirguis-Blake, J., Keppel, G. A., Holmes, J., Force, R. W., Kriegsman, W., & Baldwin, L.-M. (2018). Prescription of high-risk medications among patients with chronic kidney disease: a cross-sectional study from the Washington, Wyoming, Alaska, Montana and Idaho region Practice and Research Network. Family Practice, 35(5), 589–594. https://doi.org/10.1093/fampra/cmy001
Chicago
Guirguis-Blake, Janelle, Gina A Keppel, John Holmes, Rex W Force, William Kriegsman, and Laura-Mae Baldwin. 2018. “Prescription of High-Risk Medications among Patients with Chronic Kidney Disease: A Cross-Sectional Study from the Washington, Wyoming, Alaska, Montana and Idaho Region Practice and Research Network.” Family Practice 35 (5): 589–94. doi:10.1093/fampra/cmy001.